Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1624 1626
This examiner grants 84% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18025847 | CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE | Non-Final OA | Genzyme Corporation |
| 18557276 | METHOD FOR PREPARING XANTHINE OXIDASE INHIBITOR | Non-Final OA | LG CHEM, LTD. |
| 18263772 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITORS | Non-Final OA | LG CHEM, LTD. |
| 17636003 | MITOCHONDRIAL MODULATION TO IMPROVE METABOLIC SYNDROME DURING AGING | Non-Final OA | Shanghai Jiao Tong University |
| 18759253 | CDK2 DEGRADERS AND USES THEREOF | Non-Final OA | Kymera Therapeutics, Inc. |
| 18744031 | FORMATION OF N-PROTECTED 3,6-BIS-(4-AMINOBUTYL)-2,5-DIKETOPIPERAZINE THROUGH A CYCLIC ALPHA-N-PROTECTED AMINO ESTER INTERMEDIATE | Final Rejection | MannKind Corporation |
| 18702686 | A SYNTHESIS SCHEME AND PROCEDURES FOR PREPARING A SIK3 INHIBITOR AND INTERMEDIATES THEREOF | Non-Final OA | iOmx Therapeutics AG |
| 17785184 | UNNATURAL AMINO ACIDS AND USES THEREOF | Final Rejection | Temple University-Of The Commonwealth System of Higher Education |
| 18576412 | POLYMORPHS OF PONESIMOD | Non-Final OA | TEVA CZECH INDUSTRIES S.R.O |
| 18561624 | NOVEL CINNAMAMIDE DERIVATIVES AND USE THEREOF | Non-Final OA | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| 18540743 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | Final Rejection | The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Hol |
| 18561634 | OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION | Non-Final OA | TSUBOTA LABORATORY, INC. |
| 18561712 | TREATMENT OF ANTIPHOSPHOLIPID SYNDROME USING S-HYDROXYCHLOROQUINE | Non-Final OA | Genovate Biotechnology Co. Ltd. |
| 18009206 | QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | Final Rejection | IDEAYA BIOSCIENCES, INC. |
| 18287612 | sGC STIMULATORS | Non-Final OA | Tisento Therapeutics Inc. |
| 18549124 | COMPOSITION OF THE PHYTOCOMPOUNDS INTENDED TO ENHANCE CYTOTOXIC ACTIVITY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | Non-Final OA | FUNDACJA GETRESPONSE CARES |
| 18457560 | EP300/CBP MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | Miracure Biotechnology Limited |
| 18262777 | PROCESS FOR MANUFACTURING A DIPHENYLPHRAZINE DERIVATIVE | Non-Final OA | ACTELION PHARMACEUTICALS LTD |
| 18275880 | ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | Non-Final OA | X-Biotix Therapeutics, Inc. |
| 18267313 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | Non-Final OA | LT MATERIALS CO., LTD. |
| 18015040 | NOVEL COMPOUNDS AND METHODS FOR INCREASING KLOTHO GENE EXPRESSION | Final Rejection | KLOTHO THERAPEUTICS, INC. |
| 17801477 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Non-Final OA | Suzhou Abogen Biosciences Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy